Novartis moves to dismiss Walmart's US antitrust claims over generic drugs
MLex Summary: Novartis AG has moved to dismiss Walmart's first amended US antitrust claims over generic drugs, arguing that Walmart does not establish personal jurisdiction over Novartis, and its attempt to...To view the full article, register now.
Already a subscriber? Click here to view full article